Your browser doesn't support javascript.
loading
A Case of Locally Advanced Fibrosarcoma in a Young Male.
Raza, Ali; Siraj, Imrana; Malik, Sabina; Mohammed, Raji; Shariff, Masood A.
Affiliation
  • Raza A; Surgical Oncology, New York City (NYC) Health and Hospitals Corporation (HHC) Lincoln, Bronx, USA.
  • Siraj I; Cancer Center Research Services, New York City (NYC) Health and Hospitals Corporation (HHC) Lincoln, Bronx, USA.
  • Malik S; Cancer Center, New York City (NYC) Health and Hospitals Corporation (HHC) Lincoln, Bronx, USA.
  • Mohammed R; Pathology and Laboratory Medicine, New York City (NYC) Health and Hospitals Corporation (HHC) Lincoln, Bronx, USA.
  • Shariff MA; Surgical Oncology, New York City (NYC) Health and Hospitals Corporation (HHC) Lincoln, Bronx, USA.
Cureus ; 15(8): e44095, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37750151
ABSTRACT
Fibrosarcoma is a rare, highly malignant tumor that develops from uncontrolled overgrowth of fibroblastic cells. It may start as a painless lump or swelling under the skin. But as it grows, it can push surrounding structures - organs, muscles, nerves, or blood vessels - and lead to pain and tenderness. The treatment of fibrosarcoma depends on several factors such as size, grade, location of primary tumor, extent of spread, age, and general health condition of the patient. The main treatment is surgical removal of the primary tumor with wide-margin excision and amputation if localized in the limb. Prior to surgical intervention, radiotherapy can be applied to reduce the tumor size or following surgery to lower the risk of recurrence. Chemotherapy is indicated in cases of metastasis. Unfortunately, the prognosis of fibrosarcoma is not favorable. For high-grade fibrosarcoma, the five-year survival rate is around 30% and for low-grade fibrosarcoma, it is 50-80%, with recurrence in the first two to five years post-surgery. We encountered a case of high-grade fibrosarcoma with aggressive growth in a 36-year-old male, requiring above-knee amputation.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cureus Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cureus Year: 2023 Document type: Article Affiliation country: United States